July 28, 2011 -- Shares of Shijiazhuang Yiling Pharmaceutical climbed 27% following the company’s IPO on the ChiNext exchange. As we reported last week, the company, which makes cardiovascular and cerebrovascular medicines, bumped the price of its IPO higher by one-third due to higher-than-expected demand, raising the value of the transaction to 2.25 billion RMB ($348 million). Even after the price increase, investors still bid the shares up when they began trading. More details....